|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2000-1-13
|
|
pubmed:abstractText |
Allogeneic hematopoietic stem-cell transplantation (HSCT) from HLA-identical siblings can be used to treat children with acute lymphoblastic leukemia (ALL). However, a significant proportion of patients with ALL who undergo HSCT relapse. For this reason, we prospectively evaluated a preparative regimen that included total body irradiation (TBI), thiotepa (TT), and cyclophosphamide (CY) in patients with high-risk ALL in first complete remission (CR) and in children with ALL in second CR.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:BonettiFF,
pubmed-author:CesaroSS,
pubmed-author:FavreCC,
pubmed-author:GiorgianiGG,
pubmed-author:LocatelliFF,
pubmed-author:MazzarinoII,
pubmed-author:MessinaCC,
pubmed-author:PessionAA,
pubmed-author:PortaFF,
pubmed-author:PretiMM,
pubmed-author:RondelliRR,
pubmed-author:ZeccaMM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1838-46
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10561223-Adolescent,
pubmed-meshheading:10561223-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10561223-Bone Marrow Transplantation,
pubmed-meshheading:10561223-Child,
pubmed-meshheading:10561223-Child, Preschool,
pubmed-meshheading:10561223-Cyclophosphamide,
pubmed-meshheading:10561223-Disease-Free Survival,
pubmed-meshheading:10561223-Evaluation Studies as Topic,
pubmed-meshheading:10561223-Female,
pubmed-meshheading:10561223-Graft vs Host Disease,
pubmed-meshheading:10561223-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:10561223-Humans,
pubmed-meshheading:10561223-Infant,
pubmed-meshheading:10561223-Male,
pubmed-meshheading:10561223-Nuclear Family,
pubmed-meshheading:10561223-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:10561223-Prospective Studies,
pubmed-meshheading:10561223-Remission Induction,
pubmed-meshheading:10561223-Thiotepa,
pubmed-meshheading:10561223-Transplantation Conditioning,
pubmed-meshheading:10561223-Whole-Body Irradiation
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Total body irradiation, thiotepa, and cyclophosphamide as a conditioning regimen for children with acute lymphoblastic leukemia in first or second remission undergoing bone marrow transplantation with HLA-identical siblings.
|
|
pubmed:affiliation |
Department of Pediatrics, University of Pavia, IRCCS Policlinico San Matteo, Pavia, Italy. m.zecca@smatteo.pv.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
